Your browser doesn't support javascript.
loading
miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.
Lu, Jiaojiao; Wang, Lijie; Chen, Wei; Wang, Yueling; Zhen, Shuai; Chen, Hong; Cheng, Jian; Zhou, Yuanyuan; Li, Xu; Zhao, Le.
Afiliación
  • Lu J; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China.
  • Wang L; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China; Department of Obstetrics and Gynecology, Lanzhou University Second Hospital, Lan Zhou, Shaanxi, 730030, PR China.
  • Chen W; Center for Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China.
  • Wang Y; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China.
  • Zhen S; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China.
  • Chen H; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China; School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China.
  • Cheng J; Engineering Research Center of Molecular and Neuro Imaging of Ministry of Education, School of Life Science and Technology, Xidian University, Xi'an, Shaanxi, 710071, China.
  • Zhou Y; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China.
  • Li X; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China. Electronic a
  • Zhao L; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China. Electronic a
Arch Biochem Biophys ; 661: 1-9, 2019 01.
Article en En | MEDLINE | ID: mdl-30365936
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / ARN Neoplásico / Regulación Enzimológica de la Expresión Génica / Regulación Neoplásica de la Expresión Génica / Genes Supresores de Tumor / MicroARNs / Hexoquinasa / Proteínas de Neoplasias Límite: Female / Humans Idioma: En Revista: Arch Biochem Biophys Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / ARN Neoplásico / Regulación Enzimológica de la Expresión Génica / Regulación Neoplásica de la Expresión Génica / Genes Supresores de Tumor / MicroARNs / Hexoquinasa / Proteínas de Neoplasias Límite: Female / Humans Idioma: En Revista: Arch Biochem Biophys Año: 2019 Tipo del documento: Article